EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS

被引：0
|
作者：
Meyer, S. [1 ]
Deuse, T. [2 ]
Baholli, L. [1 ]
Sattinger, E. [1 ]
Schlueter, M. [1 ]
von Stritzky, A. [1 ]
Reichenspurner, H. [2 ]
Costard-Jaeckle, A. [1 ]
机构：
[1] Univ Herzzentrum Hamburg GmbH, Klin & Poliklin Allgemeine & Intervent Kardiol, Hamburg, Germany
[2] Univ Herzzentrum Hamburg GmbH, Klin & Poliklin Herz & Gefasschirurg, Hamburg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [41] Evaluation of the efficacy and safety of the conversion from a calcineurin inhibitor to an everolimus-based therapy in maintenance renal transplant patients
    Fructuoso, A. Sanchez
    Millan, J. C. Ruiz San
    Calvo, N.
    Rodrigo, E.
    Moreno, M. A.
    Cotorruelo, J.
    Conesa, J.
    Gomez-Alamillo, C.
    Arias, M.
    Barrientos, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2148 - 2150
  • [42] Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression
    Norum, Hilde M.
    Michelsen, Annika E.
    Lekva, Tove
    Arora, Satish
    Otterdal, Kari
    Olsen, Maria Belland
    Kong, Xiang Yi
    Gude, Einar
    Andreassen, Arne K.
    Solbu, Dag
    Karason, Kristjan
    Dellgren, Goran
    Gullestad, Lars
    Aukrust, Pal
    Ueland, Thor
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (04) : 1050 - 1060
  • [43] Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant
    Malvezzi, Paolo
    Jouve, Thomas
    Rostaing, Lionel
    Experimental and Clinical Transplantation, 2016, 14 (04) : 361 - 366
  • [44] A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
    Chadban, Steven J.
    Eris, Josette Marie
    Kanellis, John
    Pilmore, Helen
    Lee, Po Chang
    Lim, Soo Kun
    Woodcock, Chad
    Kurstjens, Nicol
    Russ, Graeme
    TRANSPLANT INTERNATIONAL, 2014, 27 (03) : 302 - 311
  • [45] Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
    Cataneo-Davila, A.
    Zuniga-Varga, J.
    Correa-Rotter, R.
    Alberu, J.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4138 - 4146
  • [46] Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome
    Catalano, Gabriele
    De Simone, Paolo
    Mazzoni, Alessandro
    Ghinolfi, Davide
    Coletti, Laura
    Filipponi, Franco
    TRANSPLANT INTERNATIONAL, 2014, 27 (09) : E84 - E86
  • [47] Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment
    Dayangac, M.
    TRANSPLANTATION, 2018, 102 : 213 - 213
  • [48] Increased Risk of Venous Thromboembolism With Everolimus-Based Immunosuppression in Lung Transplant Recipients: A Case-Controlled Study.
    Schoeppler, K.
    Lyu, D.
    Grazia, T.
    Crossno, J., Jr.
    Vandervest, K.
    Zamora, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 804 - 805
  • [49] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [50] Everolimus for Calcineurin Inhibitor Minimization in Lung Transplant Recipients with Chronic Renal Insufficiency
    Schoeppler, K.
    Lyu, D.
    Kim, I.
    Grazia, T.
    Crossno, J.
    Christians, U.
    Zamora, M. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04) : S179 - S180
12345